Clinical trial
CO2 Supplement for Prophylaxis and Treatment of Acute Mountain Sickness Using Novel Device
NCT06393998 is registered in ClinicalTrials.gov with State Key Laboratory of Respiratory Disease as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CO2 Supplement for Prophylaxis and Treatment of Acute Mountain Sickness Using Novel Device
- Lead sponsor
- State Key Laboratory of Respiratory Disease
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 7, 2024
- Completion date
- September 2, 2024
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute mountain sickness, high altitude, inhalation; gas